Sign in to view content

Prospective Randomized Trial of Treat-and-Extend Intravitreal Aflibercept for Radiation Retinopathy: One-Year Outcomes

Amy C. Schefler, MD FACS FASRS

Video
Published 2022

Related

Two years visual acuity and anatomical outcomes of patients with diabetic macular oedema treated with intravitreal aflibercept in a real life setting
Marko Lukic, MD PhD FEBO FASRS
On Demand Cases, Courses, and Papers
2019
Clinical Feasibility of Ultra-rapid, Non-pharmacologic Anesthesia for Intravitreal Injection in Patients Receiving Anti-VEGF Treatment
Cagri G Besirli, MD, PhD, FASRS
Annual Meeting Talks
2018
Efficacy and Safety of Biosimilar Ranibizumab-nuna and Ranibizumab-eqrn in Clnical Use by a Consortium of Retina Specialists
Carl C. Awh, MD, FASRS
Annual Meeting Talks
2023

Category: Ocular Oncology

See more